Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CCR (CCRO3.SA)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (R$) Price Target (R$) Rating
2019-03-2211.6913.30Neutral
2019-09-1116.6716.70Neutral
2020-06-0814.9415.50Neutral
2020-12-1813.3015.90Neutral
2021-05-0713.4514.40Neutral
2021-05-2713.9814.30Neutral
2021-06-0213.90-No Rating
2021-06-0313.9014.30Neutral
2022-02-1512.7415.50Neutral

Disclosures

  • Within the past 12 months, UBS AG, its affiliates or subsidiaries has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS AG, its affiliates or subsidiaries expect to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS Group AG, its affiliates or subsidiaries beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.